in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Fresenius Kabi Buys Indian Generics and API Firm
11:11 AM MDT | April 28, 2008 | Deepti Ramesh
Fresenius Kabi (Bad Homburg, Germany), a unit of health care group Fresenius SE, says it has acquired 73.3% stake in Dabur Pharma (New Delhi) for about €139 million ($224 million). Fresenius Kabi says it has also offered to acquire a further 20% stake in Dabur Pharma for Rupees 76.50/share. The two companies have signed a share purchase agreement, and the transaction awaits regulatory approval, Fresenius Kabi says. Burman: India pharma market is attractive. Dabur Pharma is a leading global supplier of generic drugs and active pharmaceutical ingredients...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee